| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Feb 01, 2024 | Sale | $8.53 | 2,820 | 24,058 | 52,017 | Feb 02, 2024, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Jan 23, 2024 | Sale | $9.07 | 910 | 8,252 | 41,337 | Jan 25, 2024, 04:10 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | May 10, 2023 | Sale | $16.59 | 436 | 7,233 | 42,369 | May 12, 2023, 04:06 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | May 11, 2023 | Sale | $16.12 | 122 | 1,967 | 42,247 | May 12, 2023, 04:06 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Feb 02, 2023 | Sale | $22.42 | 360 | 8,071 | 42,805 | Feb 02, 2023, 06:53 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Feb 01, 2023 | Sale | $21.75 | 1,671 | 36,348 | 43,165 | Feb 02, 2023, 06:53 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Jan 24, 2023 | Sale | $21.90 | 905 | 19,823 | 35,028 | Jan 26, 2023, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Jan 25, 2023 | Sale | $21.63 | 192 | 4,153 | 34,836 | Jan 26, 2023, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Sep 13, 2022 | Sale | $28.00 | 349 | 9,772 | 35,933 | Sep 15, 2022, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | May 11, 2022 | Sale | $21.92 | 445 | 9,756 | 35,733 | May 12, 2022, 08:44 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | May 10, 2022 | Sale | $21.51 | 436 | 9,378 | 36,178 | May 12, 2022, 08:44 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | VP, Corp Controller and CAO | Jan 31, 2022 | Sale | $26.51 | 798 | 21,152 | 36,614 | Feb 02, 2022, 04:22 PM | |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | VP, Corp Controller and CAO | Jan 24, 2022 | Sale | $24.58 | 934 | 22,955 | 28,662 | Jan 26, 2022, 04:38 PM |
Menu